Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.71 |
| ▸ | HPGD | P15428 | 3/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.67 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.58 |
| ▸ | TFEB | P19484 | 1/20 | 0.57 |
| ▸ | AKR1B10 | O60218 | 5/20 | 0.56 |
| ▸ | AKR1B1 | P15121 | 5/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | APP | P05067 | 4/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | BCHE | P06276 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4629237 | 1.00 | KDM4E (0.71) | KDM4EALDH1A1HPGDSMN1; SMN2NFE2L2 | |
| SCHEMBL4421062 | 1.00 | KDM4E (0.71) | KDM4EALDH1A1HPGDSMN1; SMN2NFE2L2 | |
| SCHEMBL8872224 | 1.00 | KDM4E (0.71) | KDM4EALDH1A1HPGDSMN1; SMN2NFE2L2 | |
| SCHEMBL8872479 | 1.00 | KDM4E (0.71) | KDM4EALDH1A1HPGDSMN1; SMN2NFE2L2 | |
| Hydrochloric Acid SCHEMBL10437236 | 0.99 | KDM4E (0.73) | KDM4EALDH1A1HPGDSMN1; SMN2NFE2L2 | |
| SCHEMBL5177689 | 0.99 | KDM4E (0.73) | KDM4EALDH1A1HPGDSMN1; SMN2NFE2L2 | |
| SCHEMBL1614877 | 0.96 | KDM4E (0.73) | KDM4EALDH1A1HPGDSMN1; SMN2NFE2L2 | |
| SCHEMBL19244312 | 0.96 | KDM4E (0.73) | KDM4EALDH1A1HPGDSMN1; SMN2NFE2L2 | |
| SCHEMBL19244433 | 0.90 | KDM4E (0.72) | KDM4EALDH1A1HPGDSMN1; SMN2NFE2L2 | |
| SCHEMBL2474892 | 0.90 | KDM4E (0.72) | KDM4EALDH1A1HPGDSMN1; SMN2NFE2L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 307 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1866033-B1 | SUNSCREEN AEROSOL SPRAY | ENSIGN LABORATORIES PTY LTD (AU) | 2017-04-19 | — | — | EP | claimed |
| US-20150272844-A1 | Topical skin care formulations | HOLYFIELD LOUISE (US) | 2015-10-01 | — | — | US | claimed |
| US-9060946-B2 | Topical skin care formulations | HOLYFIELD LOUISE (US) | 2015-06-23 | — | — | US | claimed |
| US-20150132392-A1 | INORGANIC COMPOSITE POWDER COATED WITH OCTYL METHOXYCINNAMATE, AND ULTRAVIOLET BLOCKING COSMETIC COMPOSITION USING SAME | CHEMLAND. CO., LTD (KR) | 2015-05-14 | — | — | US | claimed |
| US-20150064125-A1 | Topical skin care formulations | HOLYFIELD LOUISE (US) | 2015-03-05 | — | — | US | claimed |
| US-20140322149-A1 | COMPOUND USEFUL FOR TREATING CELLULITE | SIGMA TAU IND FARMACEUTI (IT) | 2014-10-30 | — | — | US | claimed |
| US-8192506-B2 | Compositions for dyeing keratin-containing fibers | KELLY VAN GOGH, INC. (US) | 2012-06-05 | — | — | US | claimed |
| US-20110217252-A1 | COMPOUND USEFUL FOR TREATING CELLULITE | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 2011-09-08 | — | — | US | claimed |
| EP-2344153-A1 | COMPOUND USEFUL FOR TREATING CELLULITE | SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. (IT) | 2011-07-20 | — | — | EP | claimed |
| WO-2010054978-A1 | COMPOUND USEFUL FOR TREATING CELLULITE | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 2010-05-20 | — | — | WO | claimed |
| US-20090061001-A1 | SUNSCREEN AEROSOL SPRAY | ENSIGN LABORATORIES PTY LTD (AU) | 2009-03-05 | — | — | US | claimed |
| WO-2008138393-A1 | GEL USEFUL FOR THE DELIVERY OF COSMETIC ACTIVE INGREDIENTS | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 2008-11-20 | — | — | WO | claimed |
| US-20080279900-A1 | GEL USEFUL FOR THE DELIVERY OF COSMETIC ACTIVE INGREDIENTS | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE SPA (IT) | 2008-11-13 | — | — | US | claimed |
| EP-1866033-A1 | SUNSCREEN AEROSOL SPRAY | Ensign Laboratories PTY LTD (AU) | 2007-12-19 | — | — | EP | claimed |
| WO-2006099687-A1 | SUNSCREEN AEROSOL SPRAY | ENSIGN LABORATORIES PTY LTD (AU) | 2006-09-28 | — | — | WO | claimed |
| US-20040014700-A1 | Novel oligonucleotides and use of oligonucleotides modulating the expression of enzymes involved in the synthesis of melanic pigments, as depigmentation agents | LVMH RECHERCHE (FR) | 2004-01-22 | — | — | US | claimed |
| EP-0613368-B1 | SKIN REGENERATING COSMETIC COMPOSITION | CAOLA COSMETICS AND MIXED HOUS (HU) | 1997-10-08 | — | — | EP | claimed |
| US-5478561-A | Emulsifying water in mixture of mineral oils and other oils with nonionic polymeric lipophilic emulsifier, then adding more water which contains a hydrophilic emulsifier and stirring without shear until phase inversion occurs | LANCASTER GROUP AG (DE) | 1995-12-26 | — | — | US | claimed |
| US-4765977-A | HIGH MOLECULAR WEIGHT ETHYLENE-MALEIC ANHYDRIDE POLYMER AND OCULAR CHROMOPHORE | LIQUID SUNGLASSES CORPORATION, | 1988-08-23 | — | — | US | claimed |
| EP-0085334-A2 | Substantive topical compositions | PLOUGH, INC. (a Delaware corporation) (US) | 1983-08-10 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080279900-A1 | GEL USEFUL FOR THE DELIVERY OF COSMETIC ACTIVE INGREDIENTS | SLC25A20, CRAT, CUTA | KDM4E 2357/4885ALDH1A1 2427/4885HPGD 1370/4885 |
| US-20150132392-A1 | INORGANIC COMPOSITE POWDER COATED WITH OCTYL METHOXYCINNAMATE, AND ULTRAVIOLET BLOCKING COSMETIC COMPOSITION USING SAME | OSTC, ERCC4, MCCC2 | KDM4E 418/4885ALDH1A1 3150/4885HPGD 3411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.